Yuliya Vladimirovna Kolesova

Yuliya Vladimirovna Kolesova

Auto-generated profile, based on publicly available information

Yuliya Vladimirovna Kolesova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2023 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Closed access
PDF file
NTNatalia P. Teplyuk
Natalia P. Teplyuk
YKYulia V. Kolesova
Yulia V. Kolesova
DMDaria V. Mak
Daria V. Mak
ALAnfisa Lepekhova
Anfisa Lepekhova
Stepan ToshchakovStepan Toshchakov
Stepan Toshchakov
ТПТеплюк Наталия Павловна
Теплюк Наталия Павловна
Pemphigus represents a group of severe and potentially fatal autoimmune bullous diseases. Pemphigus clinical findings represents skin and/or mucous membranes keratinocytes acantholysis with intraepithelial blisters and erosions formation which is life-threatening and, if relapsed, significantly reduce the patients’ quality of life. The on-time disease diagnosis is a key to successful pemphigus management and timely treatment onset allowing intensive disease progression avoidance. The article reviews up-to-date diagnosing methods and assessment measure for monitoring pemphigus severity. In addition to standard diagnosis methods, such as clinical findings, histological examination, direct and indirect immunofluorescence, and enzyme immunoassay (ELISA), the article focuses on revieing new diagnostic and disease severity prediction approaches, such as microRNAs expression and skin and mucous membranes microbiome analysis since false positive and false negative results in histological and immunohistochemical analysis as well as the laboratories insufficient equipment makes finding pemphigus new diagnostic and prognostic methods a relevant challenge.

15 October 2020 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Open access
PDF file
OOO. Yu. Olisova
O. Yu. Olisova
NTN. P. Teplyuk
N. P. Teplyuk
OGO. V. Grabovskaya
O. V. Grabovskaya
YKYuliya V. Kolesova
Yuliya V. Kolesova
Lichen planus (LP) is a chronic inflammatory disease of skin and mucous from group of papular dermatosis, less often affecting nails and hair. The article presents photographs of patients with various clinical forms of LP for a more thorough differential diagnosis of this disease.

13 December 2024 in Bioprinting
Verified
Journal Article
Closed access
VSVsevolod V. Shishkov
Vsevolod V. Shishkov
PBPolina Yu Bikmulina
Polina Yu Bikmulina
AKAnna V. Kardosh
Anna V. Kardosh
STSergey V. Tsibulnikov
Sergey V. Tsibulnikov
EGEkaterina V. Grekova
Ekaterina V. Grekova
PTPeter S. Timashev
Peter S. Timashev

23 September 2024 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Open access
NTNatalia P. Teplyuk
Natalia P. Teplyuk
DMDaria V. Mak
Daria V. Mak
YKYuliya V. Kolesova
Yuliya V. Kolesova
ALAnfisa Lepekhova
Anfisa Lepekhova
TFTatiana Alexandrovna Fedotcheva
Tatiana Alexandrovna Fedotcheva
ТПТеплюк Наталия Павловна
Теплюк Наталия Павловна
BACKGROUND: Pemphigus is a group of potentially fatal chronic cutaneous diseases in which blisters appear on the skin and mucous membranes as a result of IgG autoantibodies binding to desmosomes in the epidermis, leading to keratinocytes acantholysis. Currently, methods to monitor disease activity and therapy efficiency using various biomarkers are being investigated. MicroRNA expression, in particular miR-338-3p, has been one of these biomarkers, as changes in miR-338-3p expression may trigger the Th1/Th2 cell imbalance and possibly be involved in the pathogenesis of the disease. AIM: This study aimed to design a protocol to evaluate the level of miR-338-3p expression in peripheral blood mononuclear cells and verify the diagnostic value of miR-338-3p expression in pemphigus. MATERIALS AND METHODS: Experimental prospective comparative study was conducted from February 2023 to February 2024 at the Dermatology Department of Sechenov University. The study included 10 patients with pemphigus in the active stage of the disease, 3 patients in remission, and 9 participants of the control group. The expression of miRNA-338-3p was analyzed by real-time polymerase chain reaction, cDNA was obtained using StemLoop method. The evaluation of miRNA-338-3p expression level was based on its comparison with the expression of U6 gene using 2-ΔΔСt method. RESULTS: The expression level of miR-338-3p was analyzed in 10 patients in the active stage of the disease (5 men, 50%; 5 women, 50%; mean age 46±10.7 years), 3 patients in remission (2 women, 66.7%; 1 man, 33.3%; mean age 57±8 years), 9 control group (8 women, 88.9%; 1 man, 11.1%; mean age 36±16.8 years). The mean expression level of miR-338-3p was 8.64 (SD±5.72) in patients with active disease, 3.38 (SD±1.44) in patients in remission, and 1.48 (SD±1.12) in controls. A statistically significant increase in the expression level of miR-338-3p was found in patients in the active disease stage compared to the control group (p=0.002). A statistically significant correlation was found between the level of miR-338-3p expression and the PDAI index score (p 0.001). CONCLUSION: Based on the data obtained in this study, it can be assumed that microRNAs are important in pemphigus, and miR-338-3p expression in particular may serve as a key element in pemphigus pathogenesis. More detailed study of microRNAs and analysis of expression variability according to clinical data may provide the basis for developing new diagnostic methods and severity scoring, allowing more accurate and less invasive diagnostic methods, as well as monitoring and predicting disease progression.

21 June 2025 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Closed access
NTNatalia P. Teplyuk
Natalia P. Teplyuk
NSNikolai lvovich Shimanovskii
Nikolai lvovich Shimanovskii
TFTatiana Alexandrovna Fedotcheva
Tatiana Alexandrovna Fedotcheva
DMDaria V. Mak
Daria V. Mak
YKYuliya V. Kolesova
Yuliya V. Kolesova
ТПТеплюк Наталия Павловна
Теплюк Наталия Павловна
BACKGROUND: Pemphigus is a group of life-threatening, chronic, progressive skin disease. To implement timely and adequate therapy aimed at preserving life and improving its quality, it is necessary to provide a diagnostic test confirming the diagnosis. AIM: This study aimed to compare the expression levels of miR-338-3p and miR-424-5p in patients with pemphigus during therapy and remission, as well as in control groups of patients with other bullous skin diseases and healthy controls, and to evaluate the diagnostic value of miR-338-3p and miR-424-5p expression. MATERIALS AND METHODS: Prospective comparative study was conducted. The study included 20 patients with active pemphigus, 15 patients in remission, 15 healthy control group participants, and 6 patients with other bullous diseases in the active stage. The expression of miRNA-338-3p and miR-424-5p was evaluated by qRT-PCR, cDNA was obtained using StemLoop technology. MicroRNA relative expression levels were analyzed based on its comparison with the expression of U6 gene using 2-ΔΔСT method. RESULTS: The expression levels of miR-338-3p and miR-424-5p were significantly higher in patients with pemphigus active stage compared to all other groups (p 0.001). There was a statistically significant relationship between miR-338-3p expression level and disease severity according to the PDAI index (p 0.001), for miR-424-5p there was also a positive correlation with severity, but with a weaker relationship. ROC analysis showed high diagnostic accuracy of miR-338-3p (AUC 0.94) and miR-424-5p (AUC 0.93) for differentiating between patients with active pemphigus and healthy controls, with sensitivity and specificity of 95.0% and 75.0%, 95.0% and 73.3%, respectively. At week 3 from the start of glucocorticosteroid therapy, miR-338-3p levels were significantly decreased in patients in the active pemphigus (p=0.035), whereas no statistically significant decrease in miR-424-5p was observed. CONCLUSION: miR-338-3p and miR-424-5p are significant in pemphigus as potential biomarkers for diagnosis and severity grade, and the expression level of miR-338-3p can be used to determine the efficacy of pathogenetic therapy.

29 November 2022 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Closed access
PDF file
OGOlga V. Grabovskaya
Olga V. Grabovskaya
NTNataliya P. Teplyuk
Nataliya P. Teplyuk
YКYuliya V. Колесова
Yuliya V. Колесова
DIDmitriy V. Ignatyev
Dmitriy V. Ignatyev
ТПТеплюк Наталия Павловна
Теплюк Наталия Павловна
Palmoplantar keratoderma is a heterogeneous group of diseases, both hereditary and acquired, affecting, as a rule, the skin of the palms and soles in the form of focal or diffuse hyperkeratotic layers. Hereditary forms are characterized by a defect in the genes encoding certain structural components of keratinocytes, which leads to the corresponding clinical manifestations. The actual method of genomic sequencing has made it possible to identify the localization of defects in certain genes for specific types of hereditary palmoplantar keratoderma, however, despite the big step in diagnosis, therapy still remains complex and can only reduce the manifestations of the disease and improve the quality of life, and not cure it completely. The authors demonstrate a clinical case of UnnaToast keratoderma in a young patient with a long history of treatment of the disease, who showed a pronounced positive dynamics from the skin process against the background of the use of local agents, as well as the use of such a physiotherapeutic method as local PUVA therapy. In addition, the article provides a clinical case of hereditary keratoderma BuschkeFischerBrauer as an example of an accidentally diagnosed disease at a dermatologists appointment.